New York/Sydney — Asian equities slipped on Wednesday as halted Covid-19 vaccine trials and an impasse in US fiscal aid package talks soured risk appetite, while the greenback held on to gains as demand firmed for safe-harbour assets.

Johnson & Johnson (J & ) on Tuesday said it was pausing a Covid-19 vaccine trial due to a study participant’s unexplained illness...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.